Bulldog Reporter is pleased to announce the winners of the 2021 Bulldog PR Awards, recognizing both the most outstanding PR and communications campaigns, and the most extraordinary individual and.
Ridgefield Park, New Jersey (Newsfile Corp. - May 20, 2021) - Bulldog Reporter is pleased to announce the winners of the 2021 Bulldog PR Awards, recognizing both the most outstanding PR and communications
News Direct: Copper Property CTL Pass Through Trust Issues Monthly Distribution Statement for April 2021
Jersey City, New Jersey (Newsfile Corp. - May 7, 2021) - Copper Property CTL Pass Through Trust ( the Trust ), has filed a Form 8-K containing its monthly report for the period ended April 30, 2021. A distribution of $0.092206 per trust certificate will be paid on May 10, 2021 to certificateholders of record as of May 7, 2021.
Additional information can be obtained on the Monthly Distribution Statement, which can be found on the Trust s website at
www.CTLTrust.net.
About Copper Property CTL Pass Through Trust
Copper Property CTL Pass Through Trust (the Trust ) was established to acquire 160 retail properties and 6 warehouse distribution centers (the Properties ) from J.C. Penney as part of its Chapter 11 plan of reorganization. The Trust s operations consist solely of owning, leasing and selling the Properties. The Trust s objective is to sell the Properties to third-party
Copper Property CTL Pass Through Trust Issues Monthly Distribution Statement for April 2021 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PDS Biotech Announces Presentation and Panel Participation at the Benzinga Biotech Small Cap Conference
Florham Park, New Jersey (Newsfile Corp. - March 17, 2021) - PDS Biotechnology Corporation (NASDAQ: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company s proprietary Versamune® T-cell activating technology, today announced that Dr. Frank Bedu-Addo, CEO of PDS Biotech, will present the company s immunotherapy platform, ongoing phase 2 clinical programs, product pipeline and upcoming milestones virtually at the Benzinga Biotech Small Cap Conference on Wednesday, March 24 at 10:05 am ET. In addition, Dr. Bedu-Addo will participate in the Cancer Immunotherapies: Fighting Cancer with the power of the Immune System panel immediately following his presentation at 10:25am ET on Wednesday, March 24.